BSHC
ABBV icon

Breed's Hill Capital’s AbbVie ABBV Stock Holding History

Breed's Hill Capital’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		$1.91M Buy
10,309
+7
+0.1% +$1.3K 0.92% 20
2025
Q1 		$2.16M Buy
10,302
+176
+2% +$34.2K 1.16% 18
2024
Q4 		$1.8M Buy
10,126
+2,686
+36% +$494K 0.94% 20
2024
Q3 		$1.47M Sell
7,440
-2
-0% -$373 1.2% 20
2024
Q2 		$1.28M Hold
7,442
– – 1.13% 21
2024
Q1 		$1.36M Sell
7,442
-200
-3% -$34.5K 1.25% 20
2023
Q4 		$1.18M Buy
+7,642
New +$1.11M 1.15% 20

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Breed's Hill Capital's ABBV Position: Q2 2025 in Review

Breed's Hill Capital increased its AbbVie (ABBV) stake by 0.07% in Q2 2025, buying an estimated $1.3K and bringing the position to 10,309 shares worth $1.91M. The position accounts for 0.92% of the portfolio, ranked #20.

Breed's Hill Capital first reported a position in ABBV in Q4 2023 and has held it in 7 quarters since. The position peaked at $2.16M in Q1 2025. 3,787 funds tracked by Wall St. Rank hold ABBV as of Q2 2025.

  • Breed's Hill Capital held 10,309 shares of AbbVie worth $1.91M as of Q2 2025.
  • Breed's Hill Capital bought 7 AbbVie shares in Q2 2025, an estimated $1.3K.
  • AbbVie made up 0.92% of Breed's Hill Capital's portfolio in Q2 2025, its #20 holding.
  • Breed's Hill Capital first reported a position in AbbVie in Q4 2023 and has held it in 7 quarters since.
  • Breed's Hill Capital's AbbVie position peaked at $2.16M in Q1 2025.
  • 3,787 funds tracked by Wall St. Rank held AbbVie as of Q2 2025.

Based on Breed's Hill Capital's 13F filing for Q2 2025, filed 8 Aug 2025.